Living with and beyond cancer

Back to results

Winner

The transforming cancer care in the community programme – overcoming the challenges presented by the UK’s increasing cancer prevalence rates

By The East of England Strategic Clinical Network, in partnership with the Eastern Academic Health Science Network, the University of East Anglia and Macmillan Cancer Support

The transforming cancer care in the community programme was set up with the aim of establishing whether an out-of-hospital care model is scalable and sustainable; better for patients; reduces the existing over-reliance on hospital-based care; and can be more cost-effective to develop services, where clinically appropriate, outside the acute setting.

It comprises seven pilot sites, and currently has 16 primary care cancer nurses and 10 support workers providing community-based support to approx. 1,000 patients. The seven teams work in excess of 86 GP practices to support cancer patients within the primary care setting.

Judges' comments

"This is an excellent programme - well structured and supporting real patients in the community. This programme has clear goals, is cost-effective and was well executed."

 

Highly commended

The Macmillan one-to-one support service

By The Newcastle upon Tyne Hospitals NHS Foundation Trust

Many people who have or have survived cancer struggle with the physical and psycho-social consequences of treatment that could be avoided or managed. There is also growing evidence to support the role of healthy lifestyle choices,  particularly exercise, in promoting better outcomes and survival rates.

The Newcastle Macmillan-One-to-One Service aims to ensure patients living with and beyond a diagnosis of cancer are supported to live as well as possible following treatment. The Newcastle Service is one of 16 implementation sites nationally and is piloting four new roles to address the concerns of patients who have needs of varying complexity.

Judges' comments

"This was a very strong entry and we believe this programme can be rolled out in other areas."

QiC Oncology 2016 partner:
Bristol-Myers Squibb
Supported by: